Clinical Characteristics and Prognosis of Secondary Acute Lymphoblastic Leukemia in Patients with Multiple Myeloma during Long-Term Thalidomide Maintenance.

J Pers Med · 2023 · PMC10055621 · PMID 36983594

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The TT2 clinical trial showed a trend toward increased solid SPM risk from the start of maintenance therapy in the TT with thalidomide maintenance versus the without thalidomide arm [ 11 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.